Septerna (SEPN) Common Equity (2023 - 2026)
Septerna (SEPN) recorded quarterly Common Equity of $378.5 million in Q1 2026, down 0.91% quarter-over-quarter from $381.9 million in Q4 2025, and up 194.55% on a YoY basis from $128.5 million in Q1 2025.
Septerna (SEPN) Common Equity (2023 - 2026) Analysis & Trends
Septerna's Common Equity history runs 4 years deep, the most recent figure standing at $378.5 million for Q1 2026.
- In Q1 2026, Common Equity rose 194.55% year-over-year to $378.5 million; the TTM figure through Mar 2026 stood at $378.5 million (up 194.55% YoY), while the FY2025 annual figure was $381.9 million, down 9.08% from the prior year.
- Common Equity was $378.5 million for Q1 2026 at Septerna, down from $381.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $420.0 million in Q4 2024 to a low of -$400.3 million in Q1 2025.
- Historically, Common Equity has averaged $111.6 million across 4 years, with a median of -$38.4 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Common Equity soared 1194.61% in 2024, then slumped 671.31% in 2025.
- A 4-year view of Common Equity shows it stood at -$38.4 million in 2023, then jumped by 1194.61% to $420.0 million in 2024, then declined by 9.08% to $381.9 million in 2025, then retreated by 0.91% to $378.5 million in 2026.
- The last three Common Equity figures came in at $378.5 million (Q1 2026), $381.9 million (Q4 2025), and $388.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 378.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 378.46 Mn |
| Dec 31, 2025 | 381.93 Mn |
| Sep 30, 2025 | 388.73 Mn |
| Jun 30, 2025 | 377.56 Mn |
| Mar 31, 2025 | -400.27 Mn |
| Dec 31, 2024 | 420.05 Mn |
| Sep 30, 2024 | -87.41 Mn |
| Jun 30, 2024 | -67.76 Mn |
| Mar 31, 2024 | -51.89 Mn |
| Dec 31, 2023 | -38.37 Mn |
| Sep 30, 2023 | -73.85 Mn |